Published in Vaccine Weekly, April 12th, 2000
Acting as a focused research team, these core scientists will help to guide the Foundation as it supports new and innovative tuberculosis vaccine development.
"What we are trying to do in the Core Scientist Program is to accelerate the transition of experimental vaccines from the research bench to the clinic. The three major areas addressed by this program are clinical trial site development, new tools for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.